CAS: 2189684-44-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lenacapavir REF: 4Z-L-205001CAS: 2189684-44-2 | - - - | To inquire | Tue 17 Dec 24 |
 | Lenacapavir REF: 3D-AL180739CAS: 2189684-44-2 | Min. 95% | 155.00 €~1,275.00 € | Tue 21 Jan 25 |
 | Lenacapavir REF: TM-T11465CAS: 2189684-44-2 | 100.00% - 99.61% | 310.00 €~2,757.00 € | Tue 28 Jan 25 |
Ref: 4Z-L-205001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Lenacapavir
CAS:2189684-44-2
Lenacapavir is a potent and selective inhibitor of viral RNA-dependent DNA polymerase (reverse transcriptase) that …
Formula:
C39H32ClF10N7O5S2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
968.28 g/mol
Ref: 3D-AL180739
| 1mg | 155.00 € | ||
| 5mg | 378.00 € | ||
| 10mg | 518.00 € | ||
| 25mg | 924.00 € | ||
| 50mg | 1,275.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Lenacapavir
CAS:2189684-44-2
Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug …
Formula:
C39H32ClF10N7O5S2
Purity:
100.00% - 99.61%
Color and Shape:
Solid
Molecular weight:
968.28
Ref: TM-T11465
| 1mg | 310.00 € | ||
| 5mg | 641.00 € | ||
| 10mg | 1,050.00 € | ||
| 25mg | 1,551.00 € | ||
| 50mg | 2,089.00 € | ||
| 100mg | 2,757.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
